US3755581036
US3755581036
Gilead Sciences, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 29.442.000.000 | 28.754.000.000 | 2.4% |
| Cost of Revenue | 6.234.000.000 | 6.251.000.000 | 0.3% |
| Gross Profit | 23.208.000.000 | 22.503.000.000 | 3.1% |
| 11.507.000.000 | 11.907.000.000 | 3.4% | |
| Operating Income | 11.701.000.000 | 10.596.000.000 | 10.4% |
| Pretax Income | 9.796.000.000 | 690.000.000 | 1319.7% |
| Net Income Common Stockholders | 8.510.000.000 | 480.000.000 | 1672.9% |
| -- | -- | -- | |
| -- | -- | -- |